Life and Health Insurance M&A
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
In many markets in Asia, regulators are introducing new risk-based capital (RBC) regimes or “upgrading” existing frameworks, with increasing consideration being given to consistency with the new International Financial Reporting Standard 17 (IFRS 17), International Capital Standards (ICS) and other capital regimes worldwide. This paper serves as an executive summary of our report that provides a comparison of key quantitative and qualitative aspects of life 13 insurance capital regimes in Asia and to show analysis of key capital results—such as capital ratio, risk charges, and factors affecting capital—based on information publicly available and from other market sources. This summary covers the highlights at a high level, such as the status of each of the regimes, their approach of evaluating liabilities, determination of the discount curve, comparison of interest rate stress factors for selected markets, and typical industry solvency ratio levels.
Life insurance capital regimes in Asia, 3rd edition
After a wave of new regulations for companies, this executive summary provides a high-level update to our last report from 2020.